文献速递慢性肾脏病

肠道微生物组在肾病患者认知功能下降中的作用

The role of the intestinal microbiome in cognitive decline in patients with kidney disease.
PubMed 文献 · Nephrol Dial Transplant · 2025-01-01

本综述关注慢性肾脏病(CKD)患者认知功能下降的多因素机制,指出肠道菌群失调在CKD中常见并参与尿毒症毒素升高,同时肠道微生物组通过短链脂肪酸、色氨酸代谢产物、神经递质、内源性大麻素样介质、胆汁酸及GLP1、CCK等激素影响肠道功能、免疫、自主神经及脑功能。综述认为肠道微生物组可能参与CKD患者认知改变,并可能成为饮食、益生元和益生菌干预的靶点。

要点

  • CKD患者认知下降常为多因素,包括血管病变、尿毒症毒素、血脑屏障渗漏及代谢内分泌改变。
  • CKD中肠道菌群失调常见并促进尿毒症毒素升高,低纤维饮食、尿素升高、久坐、肠道传输慢和多重用药是其促进因素。
  • 肠道微生物组可能参与CKD认知改变,饮食、益生元和益生菌是潜在干预方向。

核心结论

  • 肠道微生物组可能参与CKD患者认知功能的改变,并可能成为饮食、益生元和益生菌治疗的靶点。

研究设计与样本

  • 综述类文章,围绕CKD患者肠道微生物组与认知功能下降的关系进行论述,未报告系统检索范围。

主要发现

  • CKD患者认知下降的原因可能是多因素的,包括血管疾病、尿毒症毒素、血脑屏障渗漏以及代谢和内分泌变化。
  • CKD患者肠道菌群失调常见,并促进尿毒症毒素增加。
  • 肠道微生物组可调节短链脂肪酸、色氨酸代谢衍生物、神经递质、内源性大麻素样介质、胆汁酸以及GLP1、CCK等激素的局部和全身水平。
  • 这些因素可影响肠道功能、免疫、自主神经系统活动以及脑功能的多个方面,包括血脑屏障完整性、神经髓鞘形成和存活/增殖、食欲、代谢和体温调节、情绪、焦虑和抑郁、应激及局部炎症。
  • CKD患者肠道菌群组成和生物活性代谢产物产生的改变已有充分记录,并受低纤维饮食、尿素水平升高、久坐生活方式、粪便传输时间延长和多重用药促进。

临床怎么用

  • 综述提示可将肠道微生物组作为CKD患者认知功能下降的潜在干预靶点,涉及饮食、益生元和益生菌。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Cognitive decline is frequently seen in patients with chronic kidney disease (CKD). The causes of cognitive decline in these patients are likely to be multifactorial, including vascular disease, uraemic toxins, blood-brain barrier leakage, and metabolic and endocrine changes. Gut dysbiosis is common in patients with CKD and contributes to the increase in uraemic toxins. However, the gut microbiome modulates local and systemic levels of several metabolites such as short-chain fatty acids or derivatives of tryptophan metabolism, neurotransmitters, endocannabinoid-like mediators, bile acids, hormones such as glucagon-like peptide 1 (GLP1) or cholecystokinin (CCK). These factors can affect gut function, immunity, autonomic nervous system activity and various aspects of brain function. Key areas include blood-brain barrier integrity, nerve myelination and survival/proliferation, appetite, metabolism and thermoregulation, mood, anxiety and depression, stress and local inflammation. Alterations in the composition of the gut microbiota and the production of biologically active metabolites in patients with CKD are well documented and are favoured by low-fiber diets, elevated urea levels, sedentary lifestyles, slow stool transit times and polypharmacy. In turn, dysbiosis can modulate brain function and cognitive processes, as discussed in this review. Thus, the gut microbiome may contribute to alterations in cognition in patients with CKD and may be a target for therapeutic interventions using diet, prebiotics and probiotics.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Wagner CA, Frey-Wagner I, Ortiz A, et al. The role of the intestinal microbiome in cognitive decline in patients with kidney disease. Nephrol Dial Transplant. 2025. PMID: 40080091. doi:10.1093/ndt/gfae253

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。